New Products

Production Capabilities

Our robust, sophisticated science has its roots in our years of experience and our highly talented scientific professionals.  Our large pool of expert Ph.D. and technical professionals produce innovative scientific solutions, driving your project to its goal as quickly and efficiently as possible. 

Johnson Matthey Pharmaceutical Materials can provide you with:

• Wide reactor capacity range: from 5 to 2,000 gallons (22 - 7,500 litres)
• Strict cGMP control standards for laboratory production volumes
• Materials of construction either in glass-lined or Hastalloy C reactors
• Multiple stand-alone trains ensure full range of scale-up equipment
• Hydrogenation capabilities to 100 psi
• Particle-size reduction equipment
• All products are handled in Class 100,000 contamination-control rooms with HEPA filtered-air-handling systems
• Ample warehouse facilities serve our customers' growing needs
• Unrivalled security and materials control
• Adherence to FDA's current Good Manufacturing Practice (cGMP) requirements including filing a Drug Master File (DMF) with the FDA and managing a pre-approval inspection
• International compliance filing
• Strict compliance with DEA manufacturing requirements for Class I through Class V controlled substances

In addition, our business units also offer the following:

High Potency APIs:

For over 25 years, Johnson Matthey companies have been providing multi-product, kilo scale cytotoxic and highly potent active pharmaceutical ingredients (HPAIs) to the pharmaceutical industry.

At Johnson Matthey Pharma Services (USA), our potent compound laboratories are home to highly experienced staff providing robust containment chemistry services that support the world class manufacture of highly potent active pharmaceutical ingredients for both clinical and commercial use.

Our laboratories contain state of the art technology designed to allow the safe handling of HPAI up to category IV on a V scale system.  Over the years, we have literally prepared thousands of HPAI for life saving drugs, including oncologics and cytotoxics for agencies such as the National Cancer Institute.

Controlled Substances / Opiate Production

For over 200 years, the name Macfarlan Smith (UK) has been synonymous with excellence and leadership in the development and production of controlled substances/opiates.  We are the world’s largest producer of bulk opiates, providing over 83 countries with the most extensive range of products, including codeine, morphone, oxycodone, hyromorphone, fentanyls and buprenorphnie, amongst others.